These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38954949)

  • 21. Immunoglobulin E and systemic lupus erythematosus.
    Atta AM; Sousa CP; Carvalho EM; Sousa-Atta ML
    Braz J Med Biol Res; 2004 Oct; 37(10):1497-501. PubMed ID: 15448870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA.
    Fattal I; Shental N; Molad Y; Gabrielli A; Pokroy-Shapira E; Oren S; Livneh A; Langevitz P; Pauzner R; Sarig O; Gafter U; Domany E; Cohen IR
    Immunology; 2014 Feb; 141(2):276-85. PubMed ID: 24164500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG4 autoantibodies to DNA in systemic lupus erythematosus patients.
    Nagpal S; Namboodiri MS; Rao BS; Rao PV
    Int Arch Allergy Appl Immunol; 1991; 95(1):1-6. PubMed ID: 1917105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of human anti-idiotypes broadly cross reactive with anti-dsDNA antibodies from patients with Systemic lupus erythematosus.
    Zhang W; Winkler T; Kalden JR; Reichlin M
    Scand J Immunol; 2001 Feb; 53(2):192-7. PubMed ID: 11169224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in B cell development, CDR-H3 repertoire and dsDNA-binding antibody production among C57BL/6 ΔD-iD mice congenic for the lupus susceptibility loci sle1, sle2 or sle3.
    Khass M; Schelonka RL; Liu CR; Elgavish A; Morel L; Burrows PD; Schroeder HW
    Autoimmunity; 2017 Feb; 50(1):42-51. PubMed ID: 28166678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation.
    Patiño-Trives AM; Pérez-Sánchez C; Pérez-Sánchez L; Luque-Tévar M; Ábalos-Aguilera MC; Alcaide-Ruggiero L; Arias-de la Rosa I; Román-Rodríguez C; Seguí P; Espinosa M; Font P; Barbarroja N; Escudero-Contreras A; Antonio González-Reyes J; Manuel Villalba J; Collantes-Estévez E; Aguirre-Zamorano MÁ; López-Pedrera C
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2417-2430. PubMed ID: 34320837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune Response to 
    Bagavant H; Araszkiewicz AM; Ingram JK; Cizio K; Merrill JT; Arriens C; Guthridge JM; James JA; Deshmukh US
    Front Immunol; 2021; 12():635072. PubMed ID: 34122404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
    Pradhan V; Pandit P; Rajadhyaksha A; Patwardhan M; Surve P; Kamble P; Lecerf M; Bayry J; Kaveri S; Ghosh K; Nadkar MY
    J Assoc Physicians India; 2016 May; 64(5):14-18. PubMed ID: 27735143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus.
    Sohrabian A; Parodis I; Carlströmer-Berthén N; Frodlund M; Jönsen A; Zickert A; Sjöwall C; Bengtsson AA; Gunnarsson I; Rönnelid J
    Arthritis Res Ther; 2019 Nov; 21(1):259. PubMed ID: 31783909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG subclass distribution of anticardiolipin antibody in patients with systemic lupus erythematosus.
    Tsutsumi A; Koike T; Ichikawa K; Shimada K; Takabayashi K; Tomioka H; Yoshida S
    J Rheumatol; 1988 Dec; 15(12):1764-7. PubMed ID: 3265958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters.
    Al-Mughales JA
    Front Immunol; 2022; 13():850759. PubMed ID: 35359932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted Neoepitopes.
    Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Tsang-A-Sjoe MW; Bultink IE; Voskuyl AE; Bentlage AE; Vidarsson G; Wolbink G; Rispens T
    J Immunol; 2017 Jan; 198(1):82-93. PubMed ID: 27864476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
    Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
    Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus.
    Bijl M; Dijstelbloem HM; Oost WW; Bootsma H; Derksen RH; Aten J; Limburg PC; Kallenberg CG
    Rheumatology (Oxford); 2002 Jan; 41(1):62-7. PubMed ID: 11792881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H; Leung JC; Chan LY; Chan TM; Lai KN
    Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden.
    Eriksson C; Kokkonen H; Johansson M; Hallmans G; Wadell G; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2011 Feb; 13(1):R30. PubMed ID: 21342502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG human monoclonal anti-DNA autoantibodies from patients with systemic lupus erythematosus.
    Winkler TH; Jahn S; Kalden JR
    Clin Exp Immunol; 1991 Sep; 85(3):379-85. PubMed ID: 1893617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
    Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
    J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.